2017
DOI: 10.18632/aging.101202 View full text |Buy / Rent full text
|
|

Abstract: Senescent cells accumulate with aging and at sites of pathology in multiple chronic diseases. Senolytics are drugs that selectively promote apoptosis of senescent cells by temporarily disabling the pro-survival pathways that enable senescent cells to resist the pro-apoptotic, pro-inflammatory factors that they themselves secrete. Reducing senescent cell burden by genetic approaches or by administering senolytics delays or alleviates multiple age- and disease-related adverse phenotypes in preclinical models. Re… Show more

Help me understand this report

Search citation statements

Order By: Relevance
Select...
8
235
1
1

Publication Types

Select...

Relationship

0
0

Authors

Journals